SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

UPLOAD Filing

Verastem, Inc.
Date: May 16, 2025 · CIK: 0001526119 · Accession: 0000000000-25-005252

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-287235

Date
May 16, 2025
Author
Division of
Form
UPLOAD
Company
Verastem, Inc.

Letter

Re: Verastem, Inc. Registration Statement on Form S-3 Filed May 13, 2025 File No. 333-287235 Dear Daniel W. Paterson:

May 16, 2025

Daniel W. Paterson Chief Executive Officer Verastem, Inc. 117 Kendrick Street, Suite 500 Needham, Massachusetts 02494

This is to advise you that we have not reviewed and will not review your registration statement.

Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.

Please contact Chris Edwards at 202-551-6761 with any questions.

Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Thomas Danielski

Show Raw Text
<DOCUMENT>
<TYPE>TEXT-EXTRACT
<SEQUENCE>2
<FILENAME>filename2.txt
<TEXT>
 May 16, 2025

Daniel W. Paterson
Chief Executive Officer
Verastem, Inc.
117 Kendrick Street, Suite 500
Needham, Massachusetts 02494

 Re: Verastem, Inc.
 Registration Statement on Form S-3
 Filed May 13, 2025
 File No. 333-287235
Dear Daniel W. Paterson:

 This is to advise you that we have not reviewed and will not review your
registration
statement.

 Please refer to Rules 460 and 461 regarding requests for acceleration.
We remind you
that the company and its management are responsible for the accuracy and
adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action
by the staff.

 Please contact Chris Edwards at 202-551-6761 with any questions.

 Sincerely,

 Division of
Corporation Finance
 Office of Life
Sciences
cc: Thomas Danielski
</TEXT>
</DOCUMENT>